Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present three ...
CNET21h
I Tried Using AI to Help With Graphics, but It Was a Bust
How does PosterMyWall stack up? One of Canva's competitors now has AI-powered features, and we put them to the test.
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
Poster highlights robust, dose-dependent endoscopic response with VTX958 and reductions in key inflammatory markersFull analysis of Phase 2 ...
Aduro Clean Technologies Inc.: Aduro Clean Technologies to Participate in Key Industry Conferences
Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry ...
Targeted Oncology5d
UGN-102 Shows Lasting Responses in Low-Grade, Intermediate-Risk NMIBC
UGN-102 led to durable responses in low-grade, intermediate-risk bladder cancer, per phase 3 study findings at the 2025 ...